<p>Observed data (A); Modelled data (B). Pre-vac, pre-vaccination; Post-vac2, second year post-vaccination; Post-vac4, fourth year post-vaccination; Adjusted, modelled results assuming no vaccine waning, included for comparison purposes.</p
a<p>No difference in input values between healthy and at-risk populations.</p>b<p>Adjusted for the p...
Whether the protection afforded by a vaccine wanes over time and if so, by how much, are important p...
<p>Top row. Yearly incidence of HZ (average in dark green, 95% CI in light green),of natural HZ – i....
<p>Number of rotavirus hospitalisations from observed and modelled data. Adjusted data refer to mode...
<p>Reported hospitalisation events over one year by age group pre-vaccination, for observed and mode...
<p>Adjusted observed data (smoothed curves) by age group (A); Results by age group from the multiple...
<p>Distribution of (A) age at the time of vaccination, (B) age at the time of sample collection, and...
<p>2, 9, and 16yo indicate the age in years of the group that is routinely vaccinated. Catch-up indi...
<p>Seasonal age-specific vaccine exposure rates for each scenario in the model, by season (obtained ...
<p>Individuals who receive one dose while above the age of one year are fully protected. Those who r...
Additional file 1: Supplemental Figure S1. Vaccine roll-out scenarios. Supplemental Figure S2. Impac...
The upper and lower panels show the IBM and MPM, respectively. A and C: The time series data of all ...
<p>Aged <1 year (A); Aged 1–2 years (B); Aged 2–3 years (C); Aged >3 years (D). Weeks are numbered a...
<p>Vaccinated participants collected 1–2 months after 3<sup>rd</sup> dose and factors affecting vacc...
Administered doses by Apr 2, 2021 (end of follow-up time) of each vaccine and number of COVID-19 inf...
a<p>No difference in input values between healthy and at-risk populations.</p>b<p>Adjusted for the p...
Whether the protection afforded by a vaccine wanes over time and if so, by how much, are important p...
<p>Top row. Yearly incidence of HZ (average in dark green, 95% CI in light green),of natural HZ – i....
<p>Number of rotavirus hospitalisations from observed and modelled data. Adjusted data refer to mode...
<p>Reported hospitalisation events over one year by age group pre-vaccination, for observed and mode...
<p>Adjusted observed data (smoothed curves) by age group (A); Results by age group from the multiple...
<p>Distribution of (A) age at the time of vaccination, (B) age at the time of sample collection, and...
<p>2, 9, and 16yo indicate the age in years of the group that is routinely vaccinated. Catch-up indi...
<p>Seasonal age-specific vaccine exposure rates for each scenario in the model, by season (obtained ...
<p>Individuals who receive one dose while above the age of one year are fully protected. Those who r...
Additional file 1: Supplemental Figure S1. Vaccine roll-out scenarios. Supplemental Figure S2. Impac...
The upper and lower panels show the IBM and MPM, respectively. A and C: The time series data of all ...
<p>Aged <1 year (A); Aged 1–2 years (B); Aged 2–3 years (C); Aged >3 years (D). Weeks are numbered a...
<p>Vaccinated participants collected 1–2 months after 3<sup>rd</sup> dose and factors affecting vacc...
Administered doses by Apr 2, 2021 (end of follow-up time) of each vaccine and number of COVID-19 inf...
a<p>No difference in input values between healthy and at-risk populations.</p>b<p>Adjusted for the p...
Whether the protection afforded by a vaccine wanes over time and if so, by how much, are important p...
<p>Top row. Yearly incidence of HZ (average in dark green, 95% CI in light green),of natural HZ – i....
DOI
Add to ORKG